Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis (Q48394930)

11 February 2018

title

Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis (English)

1 reference

11 February 2018

author name string

Yoshinori Kajiwara

1 reference

11 February 2018

Fumiyuki Yamasaki

1 reference

11 February 2018

Seiji Hama

1 reference

11 February 2018

Kaita Yahara

1 reference

11 February 2018

Hiroyuki Yoshioka

1 reference

11 February 2018

Kazuhiko Sugiyama

1 reference

11 February 2018

Kazunori Arita

1 reference

11 February 2018

Kaoru Kurisu

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 February 2003

1 reference

11 February 2018

published in

Cancer

1 reference

11 February 2018

volume

1 reference

11 February 2018

issue

1 reference

11 February 2018

page(s)

1077-1083

1 reference

11 February 2018

https://api.crossref.org/works/10.1002%2FCNCR.11122

1 reference

7 January 2021

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Anti-apoptosis gene, survivin, and prognosis of neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

bcl-2 protein expression in tumors of the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

The Survivin saga goes in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Control of apoptosis and mitotic spindle checkpoint by survivin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Cancer gene therapy using a survivin mutant adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Bcl-2 expression and prognosis of patients with endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11122

7 January 2021

Identifiers

DOI

10.1002/CNCR.11122

1 reference

11 February 2018

1 reference

11 February 2018